#China #Hangzhou #Healinno Tech #Ultrasound Robot #Prostate Biopsy

Introduction

At the prestigious IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2025) in Hangzhou, China, Healinno Tech, in collaboration with Beijing University of Posts and Telecommunications (BUPT), introduced a groundbreaking advancement in robotic medical technology. The newly developed Ultrasound-Guided Serial-Parallel Hybrid Robot is specifically designed for transperineal prostate biopsy procedures. This innovative technology aims to streamline the biopsy process while addressing critical challenges faced by medical professionals, such as precision control and the complexity of manual interventions.

Features of the Hybrid Robot

The hybrid robot features a serial-parallel hybrid mechanism with five degrees of freedom, enhancing its adaptability and precision during needle insertion. Comprising two serial manipulators, a linear feed unit, and an ultrasound probe positioning mechanism, this robotic system can seamlessly accommodate a variety of clinical scenarios. Its design not only prioritizes flexibility but also aims to minimize discomfort for patients while ensuring optimal outcomes.

Cutting-Edge Technology and Optimization

Central to the capabilities of this hybrid robot is an innovative Quantum-behaved Particle Swarm Optimization (QPSO) algorithm. This cutting-edge optimization technique fine-tunes robotic mechanical parameters, significantly enhancing precision compared to traditional methods. The experiment results clearly indicate that the QPSO algorithm outperformed other mainstream approaches, meeting the stringent accuracy requirements prevalent in clinical settings.

In practical validation, the robot prototype demonstrated remarkable results during experimental trials involving the utilization of water and gelatin phantoms. It achieved a maximum absolute positioning error of merely 1.47 mm in water and 1.75 mm in gelatin, both metrics falling well within the acceptable clinical standards.

Clinical Relevance and Future Prospects

The introduction of this hybrid robotic system is supported by various national and local scientific projects in China, highlighting its significant contribution to the field of medical robotics. Healinno Tech is actively engaged in refining and expanding the robot's functionalities, with future features like dynamic tracking and respiratory compensation being planned. The incorporation of these capabilities will further facilitate clinical translation and practical applications in the medical field, signaling a transformative move toward advanced medical technology.

Conclusion

Healinno Tech’s unveiling of this Ultrasound-Guided Hybrid Robot at IROS 2025 marks a pivotal moment in the evolution of medical robotics. By alleviating the traditional hurdles of precision and complexity in biopsy procedures, this innovation promises to enhance the efficacy of prostate biopsies, ultimately contributing to improved patient care. The ongoing research and development present a robust outlook for the future of medical applications built on robotic technology, confirming Healinno Tech’s commitment to leading advancements in healthcare solutions.

For more information about this innovative technology, visit Healinno Tech’s official website.